Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) EBT Margin (2016 - 2025)

Regenxbio (RGNX) has 12 years of EBT Margin data on record, last reported at 221.4% in Q4 2025.

  • For Q4 2025, EBT Margin rose 2027.0% year-over-year to 221.4%; the TTM value through Dec 2025 reached 113.8%, up 15895.0%, while the annual FY2025 figure was 113.8%, 11370.0% down from the prior year.
  • EBT Margin reached 221.4% in Q4 2025 per RGNX's latest filing, down from 208.39% in the prior quarter.
  • Across five years, EBT Margin topped out at 77.13% in Q4 2021 and bottomed at 405.63% in Q1 2024.
  • Average EBT Margin over 5 years is 238.14%, with a median of 244.04% recorded in 2024.
  • Peak YoY movement for EBT Margin: crashed -26827bps in 2022, then soared 41243bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 77.13% in 2021, then crashed by -348bps to 191.14% in 2022, then plummeted by -48bps to 283.48% in 2023, then rose by 15bps to 241.68% in 2024, then rose by 8bps to 221.4% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 221.4% in Q4 2025, 208.39% in Q3 2025, and 331.91% in Q2 2025.